On June 29th, Mr. Zheng Weining, a famous philanthropist and entrepreneur with disabilities, and his team from Shenzhen Canyou Bio-Research Institute (hereinafter referred to as "the Institute") were guests of Unknown. The two sides had an in-depth exchange on the cooperation of intestinal micro-ecology to help Canyou, autistic people and elderly people's rehabilitation services. Mr. Zheng Weining expressed his expectation that Unknown can provide high-quality rehabilitation services for the disabled group and people who are enthusiastic about the public welfare of the disabled with the help of the top technological platform, scientific research results and solutions.
Mr. Zheng Weining said that Unknown Jun has a top-notch scientific research team with admirable global vision, scientific research results, and progress in pharmaceutical research; the Institute and Unknown Jun are both rooted in Shenzhen, and both have the mission of improving human health, so the two sides have a natural soil for cooperation.
At the same time, the Institute actively cooperates with research institutions and outstanding biotechnology enterprises to incubate new business models, including laboratories, rehabilitation centers, clinics and hospitals, to form a broader industrial ecology.
At present, the Institute provides rehabilitation services to the disabled, autistic people and the elderly with the help of advanced equipment. It is reported that among the vast number of people who need to undergo rehabilitation services, a significant proportion of the population have gastrointestinal, digestive and other aspects of rehabilitation needs. The Institute hopes that Unknown, as a leading microecological pharmaceutical company in China, will work together with the Institute to explore innovative and combined rehabilitation means, including intestinal bacterial transplantation and probiotics, to bring well-being and improve the quality of health for people with disabilities, autistic patients, middle-aged and elderly people and other groups.
Unknown Jun Chief Operating Officer (COO) Hao Yi and his team received Mr. Zheng Weining and his delegation. Hao Yi extended a warm welcome to Mr. Zheng Weining and expressed his admiration and appreciation for the Institute's efforts to build a leading research facility to address the employment of people with disabilities. According to Hao Yi, Unknown Jun has a leading AI+BT technology platform, which realizes the comprehensive layout and organic combination of the four major microecological drug forms, and three drug pipelines have already entered the clinical stage. Hao Yi believes that with the advantages of the technology platform and drug development results, Unknown Jun has the ability to empower the rehabilitation service field and benefit a wider range of people.
Huang Jinqun, Head of Research and Collaboration Program of Unknown Jun Clinical Department, attended the seminar and introduced how microecology can improve human health. He demonstrated the mechanism of micro-ecology interactions with autism (ASD), tumors, and other diseases, and introduced Unknown Jun's micro-ecological drug pipeline, which has produced positive repercussions effects in scientific and clinical cooperation with many hospitals across the country.
At this meeting, the two sides reached a preliminary intention to build a scientific research base, and explore upstream and downstream medical testing, development of rehabilitation programs, products into the cooperation content. At present, the Canyou Bio-Research Institute in Shenzhen to apply for rehabilitation hospitals, clinics licenses have been approved.